Utility of PSMA PET-CT in Prostate Malignancies
This course is designed for consultants who already have experience reporting FDG PET-CT scans and who wish to explore the role of PSMA PET-CT reporting as it relates to the imaging workup of patients with prostate cancer, and the role of PSMA imaging in Lutetium PSMA theranostics.
This course comprises four tutorials in total; three that provide an overview of PSMA PET-CT reporting as it relates to the imaging workup of patients with prostate cancer and a fourth tutorial that describes the role of PSMA imaging in Lutetium PSMA theranostics.
It is expected that candidates have prior knowledge of FDG PET-CT imaging before undertaking the tutorials.
Suitable for radiologists and nuclear medicine physicians who intend to train to report PSMA PET-CT, or who otherwise encounter these studies in their practice and wish to increase their confidence, for example in the role of a presenting radiologist at an MDT (Multi-Disciplinary Team).
Learning Outcomes
-
Tom Westwood
Dr Westwood is an Oncology Radiologist with a specialist interest in nuclear medicine and molecular Imaging. His experience includes a range of PET tracers including 18 FDG, 68Ga-DOTANOC, 18F-Choline and 18F-DOPA.